Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16282376)

  • 1. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress.
    Gao J; Liu X; Rigas B
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17207-12. PubMed ID: 16282376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention.
    Williams JL; Nath N; Chen J; Hundley TR; Gao J; Kopelovich L; Kashfi K; Rigas B
    Cancer Res; 2003 Nov; 63(22):7613-8. PubMed ID: 14633677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
    Nath N; Kashfi K; Chen J; Rigas B
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of action of nitric oxide-donating aspirin.
    Kashfi K; Rigas B
    Biochem Biophys Res Commun; 2007 Jul; 358(4):1096-101. PubMed ID: 17512900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo.
    Kashfi K; Borgo S; Williams JL; Chen J; Gao J; Glekas A; Benedini F; Del Soldato P; Rigas B
    J Pharmacol Exp Ther; 2005 Mar; 312(3):978-88. PubMed ID: 15528453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC; Kania J; Burnat G; Hahn EG
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.
    Hua A; Mackenzie GG; Rigas B
    Int J Oncol; 2009 Oct; 35(4):837-44. PubMed ID: 19724920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis.
    Ouyang N; Williams JL; Rigas B
    Carcinogenesis; 2006 Feb; 27(2):232-9. PubMed ID: 16141240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
    Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
    Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targets of nitric-oxide-donating aspirin in cancer.
    Kashfi K; Rigas B
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):701-4. PubMed ID: 16042578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
    Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
    J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
    Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
    J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling.
    Zhou H; Huang L; Sun Y; Rigas B
    Cancer Lett; 2009 Jan; 273(2):292-9. PubMed ID: 18805632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells.
    Spiegel A; Hundley TR; Chen J; Gao J; Ouyang N; Liu X; Go MF; Tsioulias GJ; Kashfi K; Rigas B
    Biochem Pharmacol; 2005 Oct; 70(7):993-1000. PubMed ID: 16105666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin induces growth arrest in colon cancer cells through involvement of Wnt/β-catenin/GSK-3β signaling.
    Pandurangan AK; Dharmalingam P; Sadagopan SK; Ramar M; Munusamy A; Ganapasam S
    J Environ Pathol Toxicol Oncol; 2013; 32(2):131-9. PubMed ID: 24099426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin inhibits proliferation and induces apoptosis of multiple myeloma cells through regulation of Bcl-2 and Bax and suppression of VEGF.
    Ding JH; Yuan LY; Huang RB; Chen GA
    Eur J Haematol; 2014 Oct; 93(4):329-39. PubMed ID: 24766194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NO-donating aspirin induces phase II enzymes in vitro and in vivo.
    Gao J; Kashfi K; Liu X; Rigas B
    Carcinogenesis; 2006 Apr; 27(4):803-10. PubMed ID: 16267095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-donating acetylsalicylic acid induces apoptosis in chronic lymphocytic leukemia cells and shows strong antitumor efficacy in vivo.
    Razavi R; Gehrke I; Gandhirajan RK; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
    Clin Cancer Res; 2011 Jan; 17(2):286-93. PubMed ID: 21097689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein nitration and nitrosylation by NO-donating aspirin in colon cancer cells: Relevance to its mechanism of action.
    Williams JL; Ji P; Ouyang N; Kopelovich L; Rigas B
    Exp Cell Res; 2011 Jun; 317(10):1359-67. PubMed ID: 21406194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.